Part 13Additional relief for expenditure on research and development

Chapter 7F2Relief for large companies: vaccine research etc

Annotations:
Amendments (Textual)
F2

Pt. 13 Ch. 7 heading substituted (with effect in accordance with Sch. 3 para. 38 of the amending Act) by Finance Act 2012 (c. 14), Sch. 3 para. 30

Reliefs

1091F3Amount of deduction

1

This section applies if—

a

a company makes a claim under section 1087 for relief to which it is entitled for an accounting period, F1...

F1b

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2

The amount of the deduction under that section is the sum of—

a

amount A, and

b

amount B.

3

Amount A is 40% of so much of the company's qualifying Chapter 7 expenditure for the period as is allowable as a deduction in calculating for corporation tax purposes the profits for the period of a trade carried on by the company.

4

Amount B is 140% of so much of the company's qualifying Chapter 7 expenditure for the period that is not so allowable.

5

The deduction is in addition to any other deduction in respect of the expenditure.

6

See sections 1098 and 1100 for the meaning of “qualifying Chapter 7 expenditure” and provision about when such expenditure is “for” an accounting period.